Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy

Aging (Albany NY). 2024 Jan 3;16(1):964-982. doi: 10.18632/aging.205406. Epub 2024 Jan 3.

Abstract

Immunoglobulin A nephropathy (IgAN), one type of glomerulonephritis, displays the accumulation of glycosylated IgA in the mesangium. Studies have demonstrated that both genetics and epigenetics play a pivotal role in the occurrence and progression of IgAN. Post-translational modification (PTM) has been revealed to critically participate in IgAN development and progression because PTM dysregulation results in impaired degradation of proteins that regulate IgAN pathogenesis. A growing number of studies identify that PTMs, including sialylation, o-glycosylation, galactosylation, phosphorylation, ubiquitination and deubiquitination, modulate the initiation and progression of IgAN. Hence, in this review, we discuss the functions and mechanisms of PTMs in regulation of IgAN. Moreover, we outline numerous compounds that govern PTMs and attenuate IgAN progression. Targeting PTMs might be a useful strategy to ameliorate IgAN.

Keywords: IgAN; O-glycosylation; PTM; phosphorylation; ubiquitination.

Publication types

  • Review

MeSH terms

  • Glomerulonephritis, IGA* / metabolism
  • Glomerulonephritis, IGA* / pathology
  • Glycosylation
  • Humans
  • Phosphorylation
  • Protein Processing, Post-Translational